Umoja Biopharma
WA - SeattlePharmaceutical
Focus: Umoja Biopharma is a Seattle-based cellular immunotherapy company focused on CAR-T and next-generation cell therapy platforms for oncology. The company is in Series C+ funding stage with an early-stage pipeline and modest headcount.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES C +
Open Jobs
25+10 this month
Growing — net +10 jobs in 30d
17 jobs added vs 7 removed. Steady team buildout.
Should You Work at Umoja Biopharma?
AI assessmentUmoja is a high-risk, early-stage immunotherapy play suitable for risk-tolerant professionals seeking foundational roles in a cell therapy platform company with modest but focused hiring.
Why Work Here
- Ground-floor opportunity in cellular immunotherapy, a high-validation modality with significant commercial upside if pipeline progresses
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SCRI-E2CAR_EGFRtv1
OsteosarcomaClinical Trials (1)
NCT05312411A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma
Phase 1Help build intelligence for Umoja Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.